Pictet Asset Management (UK)’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-994,476
Closed -$3.4M 1824
2020
Q4
$3.4M Sell
994,476
-57,900
-6% -$110K ﹤0.01% 886
2020
Q3
$1.51M Sell
1,052,376
-51,900
-5% -$92.4K ﹤0.01% 924
2020
Q2
$2.2M Sell
1,104,276
-97,800
-8% -$192K ﹤0.01% 851
2020
Q1
$2.34M Buy
1,202,076
+502,700
+72% +$1.5M 0.01% 826
2019
Q4
$2.9M Sell
699,376
-30,500
-4% -$117K 0.01% 873
2019
Q3
$2.2M Buy
729,876
+64,100
+10% +$198K ﹤0.01% 853
2019
Q2
$4.19M Buy
665,776
+78,926
+13% +$472K 0.01% 740
2019
Q1
$3.26M Buy
586,850
+175,400
+43% +$1.07M 0.01% 785
2018
Q4
$2.73K Buy
411,450
+142,200
+53% +$1.15M 0.01% 786
2018
Q3
$2.87M Sell
269,250
-24,400
-8% -$280K 0.01% 852
2018
Q2
$3.52M Sell
293,650
-110,000
-27% -$1.13M 0.01% 729
2018
Q1
$3.46M Buy
403,650
+143,100
+55% +$1.32M 0.01% 723
2017
Q4
$2.57M Buy
260,550
+185,300
+246% +$1.93M 0.01% 782
2017
Q3
$925K Buy
75,250
+7,300
+11% +$108K ﹤0.01% 835
2017
Q2
$941K Buy
67,950
+6,400
+10% +$99.1K ﹤0.01% 823
2017
Q1
$883K Buy
61,550
+6,800
+12% +$101K ﹤0.01% 822
2016
Q4
$757K Buy
+54,750
New +$878K ﹤0.01% 812

Other funds holding LXRX